944 related articles for article (PubMed ID: 32312382)
1. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
Elife; 2020 Apr; 9():. PubMed ID: 32312382
[TBL] [Abstract][Full Text] [Related]
2. eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin.
Ninchoji T; Love DT; Smith RO; Hedlund M; Vestweber D; Sessa WC; Claesson-Welsh L
Elife; 2021 Apr; 10():. PubMed ID: 33908348
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
4. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
[TBL] [Abstract][Full Text] [Related]
6. Dietary Compound Chrysin Inhibits Retinal Neovascularization with Abnormal Capillaries in db/db Mice.
Kang MK; Park SH; Kim YH; Lee EJ; Antika LD; Kim DY; Choi YJ; Kang YH
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27918469
[TBL] [Abstract][Full Text] [Related]
7. Activation of Vascular Endothelial Growth Factor (VEGF) Receptor 2 Mediates Endothelial Permeability Caused by Cyclic Stretch.
Tian Y; Gawlak G; O'Donnell JJ; Birukova AA; Birukov KG
J Biol Chem; 2016 May; 291(19):10032-45. PubMed ID: 26884340
[TBL] [Abstract][Full Text] [Related]
8. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd.
Sun Z; Li X; Massena S; Kutschera S; Padhan N; Gualandi L; Sundvold-Gjerstad V; Gustafsson K; Choy WW; Zang G; Quach M; Jansson L; Phillipson M; Abid MR; Spurkland A; Claesson-Welsh L
J Exp Med; 2012 Jul; 209(7):1363-77. PubMed ID: 22689825
[TBL] [Abstract][Full Text] [Related]
9. VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread.
Li X; Padhan N; Sjöström EO; Roche FP; Testini C; Honkura N; Sáinz-Jaspeado M; Gordon E; Bentley K; Philippides A; Tolmachev V; Dejana E; Stan RV; Vestweber D; Ballmer-Hofer K; Betsholtz C; Pietras K; Jansson L; Claesson-Welsh L
Nat Commun; 2016 Mar; 7():11017. PubMed ID: 27005951
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy.
Simmons AB; Bretz CA; Wang H; Kunz E; Hajj K; Kennedy C; Yang Z; Suwanmanee T; Kafri T; Hartnett ME
Angiogenesis; 2018 Nov; 21(4):751-764. PubMed ID: 29730824
[TBL] [Abstract][Full Text] [Related]
12. Targeting VEGF-A/VEGFR2 Y949 Signaling-Mediated Vascular Permeability Alleviates Hypoxic Pulmonary Hypertension.
Zhou W; Liu K; Zeng L; He J; Gao X; Gu X; Chen X; Jing Li J; Wang M; Wu D; Cai Z; Claesson-Welsh L; Ju R; Wang J; Zhang F; Chen Y
Circulation; 2022 Dec; 146(24):1855-1881. PubMed ID: 36384284
[TBL] [Abstract][Full Text] [Related]
13. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
14. Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye.
Huang H; Shen J; Vinores SA
PLoS One; 2011; 6(6):e21411. PubMed ID: 21731737
[TBL] [Abstract][Full Text] [Related]
15. KIF13B mediates VEGFR2 recycling to modulate vascular permeability.
Cho HD; Nhàn NTT; Zhou C; Tu K; Nguyen T; Sarich NA; Yamada KH
Cell Mol Life Sci; 2023 Mar; 80(4):91. PubMed ID: 36928770
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.
Geisen P; Peterson LJ; Martiniuk D; Uppal A; Saito Y; Hartnett ME
Mol Vis; 2008 Feb; 14():345-57. PubMed ID: 18334951
[TBL] [Abstract][Full Text] [Related]
17. VEGF-A165b is cytoprotective and antiangiogenic in the retina.
Magnussen AL; Rennel ES; Hua J; Bevan HS; Beazley Long N; Lehrling C; Gammons M; Floege J; Harper SJ; Agostini HT; Bates DO; Churchill AJ
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4273-81. PubMed ID: 20237249
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation.
Lee CS; Kim YG; Cho HJ; Park J; Jeong H; Lee SE; Lee SP; Kang HJ; Kim HS
Sci Rep; 2016 Jul; 6():29393. PubMed ID: 27381080
[TBL] [Abstract][Full Text] [Related]
20. Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells.
Nakamura Y; Patrushev N; Inomata H; Mehta D; Urao N; Kim HW; Razvi M; Kini V; Mahadev K; Goldstein BJ; McKinney R; Fukai T; Ushio-Fukai M
Circ Res; 2008 May; 102(10):1182-91. PubMed ID: 18451337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
